Skip to content

Gross Profit at other companies

Medtronic logo
MedtronicMDT
$6.41B+10.9%
LivaNova logo
LivaNovaLIVN
$243.75M+12.7%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$7.76M+51.1%
Inspire Medical Systems logo
Inspire Medical SystemsINSP
$176.91M+3.7%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$134.92M+9.2%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$243.27M+8.6%

Other financials

Income statement

See full
Revenue$22.1M-2.0%
Operating income-$5.6M-8.2%
Net income-$6.7M-1.5%
EPS (diluted)-$0.20+4.8%

Balance sheet

See full
Cash & equivalents$15.6M-42.4%
Total debt$70.5M-3.7%
Total equity$14.5M-40.4%
Total assets$98.9M-10.3%

Cash flow

See full
Operating cash flow-$5.9M+21.1%
CapEx$117.0K+216%
Free cash flow-$6.0M+20.0%

Valuation

See full
Market cap$557.77M+63.4%
Enterprise value$612.6M+58.1%
P/S5.6×+1.6×

Profitability

See full
Gross margin78.3%+3.5pp
Operating margin-16.8%-3.5pp
Net margin-21.7%-4.5pp
FCF margin-10.3%-3.5pp

Returns & leverage

See full
Return on equity-111.4%-13.1pp
Debt / equity4.9×+1.9×
Current ratio5.4×-1.2×

Where this comes from

Calculated from Neuropace, Inc.’s reported figures.

The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuropace, Inc.'s gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neuropace, Inc.'s gross profit?
Neuropace, Inc. (NPCE) reported gross profit of $18.05M in Q1 2026.
How has Neuropace, Inc.'s gross profit changed year-over-year?
Neuropace, Inc.'s gross profit increased by 4.1% year-over-year, from $17.34M to $18.05M.
What is the long-term trend for Neuropace, Inc.'s gross profit?
Over 4 years (2021 to 2025), Neuropace, Inc.'s gross profit has grown at a 23.3% compound annual growth rate (CAGR), from $33.44M to $77.22M.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.